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Abstract: Blood glucose (BG) control is a major difficulty
during liver transplantation (LT). A model-based approach
to analysis and control can enhance the efficiency of BG
management during LT surgery. An existing clinically val-
idated metabolic model was fitted to data from 8 LT pa-
tients. The reperfusion part of the post-anhepatic phase of
LT shows a clear consistent dynamic rise in blood glucose
(BG) level that would enable better prediction of future BG
in this phase. Model fitting errors showed that the funda-
mental model captured all primary dynamics but parameter
adjustment to reflect known conditions during LT surgery in
specific phases would improve model quality.
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Introduction
The liver is the primary metabolic organ in maintaining sta-
ble blood glucose (BG) levels by the storage or release of
glucose from nutrition [1]. Blood glucose (BG) evolution
is highly variable and difficult to control for liver trans-
plant (LT) patients during and after surgery, particularly af-
ter reperfusion in the post-anhepatic phase [2] [3] [4]. Fig.1
shows this behaviour and how the BG level increases signif-
icantly and variably during reperfusion. However, effective
BG management to moderate BG levels can enhance recov-
ery and transplanted liver function [5].
LT surgery is thus a major metabolic challenge. BG con-
trol is severely limited, and effectively unpredictable based
on normal assumptions about metabolic function. Hence,
model-based analysis and control can provide improved
management and outcomes.
Methods
This paper examines BG evolution in LT patients and
the ability of an existing metabolic model to capture the
observed dynamics. The second goal is to determine the
fundamental dynamics of BG during this surgery and the
reperfusion phase in particular, to define the sudden BG
rise that confounds BG control.
Data: Data from 8 LT patients in the Budapest Transplan-
tation clinic. All insulin, glucose infusion, and BG data
Figure 1: BG evolution for 8 LT patients (A- H). The
first filled area represents the anhepatic phase until reper-
fusion. The second (white) section is the part of the post-
anhepatic phase, the clinical data show a consistent dy-
namic behaviour. The third (grey) section can be considered
as a normalized metabolic function.
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were recorded by blood gas analyser, plus relevant clinical
data on each patient. Times for each major surgical step
were recorded.
ICING2 model: The ICING2 model is a clinically vali-
dated metabolic model [6]. The model is identified using
the clinical data. Ability to capture observed dynamics is
assessed using mean absolute percentage error (MAPE) of
fitted BG values for each phase of LT surgery in Fig.1.
Reperfusion Dynamics: The second, reperfusion phase
clinical data showed similar dynamics for each patient.
Each BG sequence for this phase is overlaid and normalised
to determine if there are a fundamental dynamic that would
enable better BG control.
Table 1: Mean absolute percentage error (MAPE [%]) of
the fitting for the certain timeintervals introduced in Fig. 1
Patient section1 section2 section3
A 1.3532 6.5192 0.1943
B 0.6324 12.9562 0.8889
C 2.6865 1.0268 0.9930
D 8.5483 5.0351 0.1116
E 9.1447 3.1377 0.9344
F 0.8299 18.7366 0.9223
G 3.5302 1.5578 0.4648
H 11.1833 22.4083 0.7561
Results
Table 1 shows the MAPE results primarily within measure-
ment errors of 7-12% for all phases, although Patient H is
relatively larger. There are some outliers that show addi-
tional model dynamics may need to be considered.
Fig. 2 shows the normalised reperfusion BG dynamics and
an identified polynomial function. There is a clear, consis-
tent dynamic rise in BG. The function captures this rise and
can be used to improve BG prediction and control as the
timeframes are exactly known.
Discussion
The model fitting errors of Table 1 indicate that the model
will require some adjustment of parameters for LT patients.
This result is expected because the model was defined and
used for ICU patients with some measure of liver function.
The LT case is quite different but the model has specific ad-
justable parameters.
The polynomial curve of Fig. 1 will enable better control.
It captures a predictable, consistent dynamic that can be
based on known surgical timing. This approach thus allows
far better prediction of future behaviours and thus far better
control of the BG levels to enable better recovery [5].
Figure 2: The second, reperfusion phase of the clinical data.
The sequences are normalized and overlaid. A fitted poly-
nomial function shows a consistent dynamic of blood glu-
cose evolution.
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